{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:00:30Z","timestamp":1785859230247,"version":"3.56.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1097\/01.mbc.0000214710.19116.40","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T04:03:48Z","timestamp":1139889828000},"page":"147-149","source":"Crossref","is-referenced-by-count":26,"title":["Fondaparinux as anticoagulant in a pregnant woman with heparin allergy"],"prefix":"10.1097","volume":"17","author":[{"given":"Ajith","family":"Wijesiriwardana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David AR","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210203","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1055\/s-0038-1649949","article-title":"Absence of in viro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia","volume":"74","author":"Elalamy","year":"1995","journal-title":"Thromb Haemost"},{"key":"R2-9-20210203","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00001721-199703000-00005","article-title":"Absence of cross-reactivity of SR90107A\/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia","volume":"8","author":"Amiral","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R3-9-20210203","first-page":"32","article-title":"Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins","volume":"88","author":"Parody","year":"2003","journal-title":"Haematologica"},{"key":"R4-9-20210203","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00001721-200312000-00013","article-title":"Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium","volume":"14","author":"Blackstein","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R5-9-20210203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00001721-200307000-00009","article-title":"Prophylactic use of danaparoid in high-risk pregnancy with heparin-induced thrombocytopaenia-positive skin reaction","volume":"14","author":"Myers","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R6-9-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-200103000-00011","article-title":"Management of heparin allergy during pregnancy with danaparoid","volume":"12","author":"Harrison","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R7-9-20210203","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ajh.1129","article-title":"Management of heparin allergy in pregnancy","volume":"67","author":"Aijaz","year":"2001","journal-title":"Am J Hematol"},{"key":"R8-9-20210203","first-page":"64","article-title":"Fatal anaphylactic shock caused by lepirudin.","volume":"64","year":"2003","journal-title":"Prescrire Int"},{"key":"R9-9-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1527-3466.2002.tb00081.x","article-title":"Fondaparinux, a synthetic pentasaccharide; the first in a new class of antithrombotic agents \u2013 the selective factor Xa inhibitors","volume":"20","author":"Aauer","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"R10-9-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00062752-200309000-00001","article-title":"Fondaparinux, the first selective factor Xa inhibitor","volume":"10","author":"Turpie","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"R11-9-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-1873.2004.00399.x","article-title":"Fondaparinx; a suitable alternative in delayed-type allergy to heparins and semi-synthetic heparinoids? A study of 7 cases","volume":"51","author":"Jappe","year":"2004","journal-title":"Contact Dermatitis"},{"key":"R12-9-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1398-9995.2003.00373.x","article-title":"Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy","volume":"59","author":"Maetzke","year":"2004","journal-title":"Allergy Net"},{"key":"R13-9-20210203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1398-9995.2005.00695.x","article-title":"Unexpected delayed-type hypersensitivity reactions to ultra-low-molecular-weight heparin fondaparinux","volume":"60","author":"Maetzke","year":"2005","journal-title":"Allergy Net"},{"key":"R14-9-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-1873.2004.0426c.x","article-title":"Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux","volume":"51","author":"Hohenstein","year":"2004","journal-title":"Contact Dermatitis"},{"key":"R15-9-20210203","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1055\/s-0037-1613092","article-title":"Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfuse human cotyledon in vitro","volume":"87","author":"Lagrange","year":"2002","journal-title":"Thromb Haemost"},{"key":"R16-9-20210203","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","article-title":"Minor transplacental passage of fondaparinux in vivo","volume":"350","author":"Dempfle","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200603000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:07:53Z","timestamp":1785856073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200603000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000214710.19116.40","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}